Christine Tan
About Christine Tan
Christine Tan is a Senior Scientist in Biotherapeutics Discovery at Bristol Myers Squibb with over 20 years of experience in antibody discovery and engineering.
Current Role at Bristol Myers Squibb
Christine Tan is currently working as a Senior Scientist in Biotherapeutics Discovery at Bristol Myers Squibb. She is based in Redwood City, California. In this role, Christine leverages her extensive experience in antibody discovery and engineering to contribute to the advancement of biotherapeutic development.
Previous Experience at Apexigen
Prior to her current role, Christine Tan worked at Apexigen, initially as an Antibody Discovery Manager from 2015 to 2020, and later as an Antibody Discovery Manager II from 2021 to 2022. During her tenure at Apexigen in San Carlos, California, she managed multiple antibody discovery projects and led scientific research teams.
Long-Term Tenure at Genentech
Christine Tan spent 17 years at Genentech, working as a Senior Scientific Researcher in Antibody Discovery and Engineering from 1998 to 2015. Based in South San Francisco, California, she played a significant role in the development of several antibody-based therapies and contributed to the scientific community's understanding of biotherapeutics discovery processes.
Educational Background in Biochemistry
Christine Tan studied Biochemistry at the University of California, Davis, where she earned her Bachelor's Degree. Her educational background laid the foundation for her career in biotherapeutics discovery and antibody engineering.
Over 20 Years of Experience in Antibody Discovery
Christine Tan has over 20 years of professional experience in antibody discovery and engineering. Throughout her career, she has managed and led scientific research teams, contributing to the development of new biotherapeutic products and therapies. Her deep understanding of biotherapeutics discovery processes and methodologies underscores her expertise in the field.